241 related articles for article (PubMed ID: 6219490)
1. Platelet factor release following heparin administration and during extracorporeal circulation.
Flicker W; Milthorpe BK; Schindhelm K; Odell RA; McPherson J; Farrell PC
Trans Am Soc Artif Intern Organs; 1982; 28():431-6. PubMed ID: 6219490
[No Abstract] [Full Text] [Related]
2. Objective assessment of heparin requirements for hemodialysis in humans.
Ireland H; Lane DA; Curtis JR
J Lab Clin Med; 1984 Apr; 103(4):643-52. PubMed ID: 6230409
[TBL] [Abstract][Full Text] [Related]
3. The relationship between plasma levels of the factor VIII complex and platelet release products (beta-thromboglobulin and platelet factor 4) in children with the hemolytic-uremic syndrome.
Appiani AC; Edefonti A; Bettinelli A; Cossu MM; Paracchini ML; Rossi E
Clin Nephrol; 1982 Apr; 17(4):195-9. PubMed ID: 6176380
[No Abstract] [Full Text] [Related]
4. Platelet activation and allergic asthma.
Gresele P; Todisco T; Merante F; Nenci GG
N Engl J Med; 1982 Mar; 306(9):549. PubMed ID: 6173752
[No Abstract] [Full Text] [Related]
5. Hemodynamic and platelet response to the bolus intravenous administration of porcine heparin.
Bjoraker DG; Ketcham TR
Thromb Haemost; 1983 Feb; 49(1):1-4. PubMed ID: 6221433
[TBL] [Abstract][Full Text] [Related]
6. Effects of pressure excursions on human platelets. In vitro studies on betathromboglobulin (beta-TG) and platelet factor 4 (PF4) release and on platelet sensitivity to ADP-aggregation.
Torsellini A; Becucci A; Citi S; Cozzolino F; Guidi G; Lombardi V; Vercelli D; Veloci M
Haematologica; 1982; 67(6):860-6. PubMed ID: 6186580
[No Abstract] [Full Text] [Related]
7. Platelet specific proteins in Bernard-Soulier syndrome.
Devaraj R; Prowse C; Dawes J; Toolis F
Thromb Haemost; 1979 Dec; 42(4):1349. PubMed ID: 94471
[No Abstract] [Full Text] [Related]
8. Heparin is unable to prevent contact activation by three different membranes.
Stratta P; Canavese C; Mangiarotti G; Pacitti A; Tetta C; Coppo R; Ragni R; Vercellone A
Proc Eur Dial Transplant Assoc; 1981; 18():269-74. PubMed ID: 6460241
[TBL] [Abstract][Full Text] [Related]
9. Platelet activation in response to phlebotomy. An experimental study of healthy blood donors.
Eriksson KA; Sigvaldason A; Lindholm A; Safai-Kutti S; Kutti J
Acta Med Scand; 1982; 212(3):121-3. PubMed ID: 6183925
[TBL] [Abstract][Full Text] [Related]
10. Warning: platelet factor 4, beta-thromboglobulin and thromboxane in donor's plasma units.
Stratta P; Canavese C; Peiretti F; Vallauri P; Vercellone A
Thromb Haemost; 1983 Feb; 49(1):61. PubMed ID: 6189235
[No Abstract] [Full Text] [Related]
11. Intraglomerular localization of platelet related antigens, platelet factor 4 and beta-thromboglobulin in glomerulonephritis.
Duffus P; Parbtani A; Frampton G; Cameron JS
Clin Nephrol; 1982 Jun; 17(6):288-97. PubMed ID: 6179675
[TBL] [Abstract][Full Text] [Related]
12. [Determination of platelet activation products (platelet factor IV and beta-thromboglobulin) in a group of workers with long-term exposure to carbon disulfide].
Craveri A; Lanfredini M; Tornaghi G; Frangione A; Milella AM; Ranieri R; Tonali M; Gatti L; Franco G; Moia M
G Clin Med; 1980 Nov; 61(11):812-21. PubMed ID: 6165639
[No Abstract] [Full Text] [Related]
13. Does the beta-TG/PF4 ratio have any value?
Arocha-Piñango CL; Ojeda A
Thromb Haemost; 1983 Apr; 49(2):147. PubMed ID: 6191402
[No Abstract] [Full Text] [Related]
14. [Levels of beta-thromboglobulin and platelet factor 4 in various diseases (author's transl)].
Matsuda T; Seki T; Ogawara M; Miura R; Yokouchi M; Murakami M
Nihon Ketsueki Gakkai Zasshi; 1980 Oct; 43(5):871-8. PubMed ID: 6165213
[No Abstract] [Full Text] [Related]
15. Plasma beta-thromboglobulins and platelet factor 4 during the normal menstrual cycle.
Motomiya T; Yamazaki H
Nihon Ketsueki Gakkai Zasshi; 1981 Feb; 44(1):193-5. PubMed ID: 6171983
[No Abstract] [Full Text] [Related]
16. [Correlations of beta-thromboglobin, platelet factor IV and the course of the hemolytic-uremic syndrome in children].
Claris Appiani A; Bettinelli A; Cossu MM; Edefonti A; Ghio L; Giani M; Pieretti A; Paracchini ML; Tantalo V; Rossi E
Minerva Nefrol; 1980; 27(4):677-82. PubMed ID: 6166907
[No Abstract] [Full Text] [Related]
17. Platelet markers of thromboembolic disease.
Wohl H
West J Med; 1981 Jul; 135(1):19-24. PubMed ID: 6167074
[TBL] [Abstract][Full Text] [Related]
18. The effects of Carmeda Bioactive Surface on human blood components during simulated extracorporeal circulation.
Korn RL; Fisher CA; Livingston ER; Stenach N; Fishman SJ; Jeevanadam V; Addonizio VP
J Thorac Cardiovasc Surg; 1996 May; 111(5):1073-84. PubMed ID: 8622305
[TBL] [Abstract][Full Text] [Related]
19. [Plasma levels of beta-thromboglobulin and platelet factor 4 in clinical conditions (author's transl)].
Motomiya T; Yahara Y; Onozawa Y; Watanabe C; Tomura S; Sano T; Yamazaki H
Nihon Ketsueki Gakkai Zasshi; 1980 Oct; 43(5):864-70. PubMed ID: 6165212
[No Abstract] [Full Text] [Related]
20. The effect of anticoagulant mixtures on BTG and PF4 levels.
Randi ML; Fabris F; Casonato A; Girolami A
Thromb Haemost; 1981 Aug; 46(2):569. PubMed ID: 6171043
[No Abstract] [Full Text] [Related]
[Next] [New Search]
